ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
PlasmidFactory is the second investment of ArchiMed’s MED Platform II, which began fundraising in January.
